Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade

Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade

Summary: Background: Whether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an important concern for anti-IL-6 therapy. We aimed to investigate the effects of IL-6 blockade on long-term immunity to SARS-CoV-2. Methods: Prosp...

Full description

Bibliographic Details
Main Authors: Mar Masiá, Marta Fernández-González, José Alberto García, Sergio Padilla, Javier García-Abellán, Ángela Botella, Paula Mascarell, Vanesa Agulló, Félix Gutiérrez
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:EBioMedicine
Subjects:
SARS-CoV-2
COVID-19
Interleukin-6 blockade
Tocilizumab
Antibody responses
T-cell responses
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422003346

Internet

http://www.sciencedirect.com/science/article/pii/S2352396422003346

Similar Items